Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InvestPrivate, Inc. was a specialized investment bank and broker-dealer that focused on the biotechnology and life sciences sectors. Founded in 1998 by Scott Mathis, the firm provided capital raising and advisory services to emerging biotech companies, often through private placements and venture capital rounds. It operated in conjunction with its research affiliate, InvestBio, and its parent company, Diversified Biotech Holdings Corporation. The firm was a notable participant in the early 2000s biotech funding landscape, serving as a placement agent for companies like Repligen and Tigris Pharmaceuticals before rebranding as DPEC Capital and eventually transitioning into Gaucho Group Holdings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InvestPrivate.